Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2024-07-15 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
ACQUISITION OF AMOLYT PHARMA COMPLETED
Foreign Filer Report
2024-07-15 English
Acquisition of Amolyt Pharma completed
Regulatory Filings Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 2924W) on July 15, 2024, detailing the 'Acquisition of Amolyt Pharma completed'. This announcement describes a significant corporate transaction (M&A activity) and provides financial considerations related to the deal. While it discusses a transaction, the core event being reported is the completion of a merger/acquisition. The most fitting category is M&A Activity (TAR). It is not a general regulatory filing (RNS) because it is highly specific to a corporate transaction, nor is it a general earnings release (ER) or a comprehensive report (10-K/IR).
2024-07-15 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2024-07-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official notification released via RNS (Regulatory News Service) with the RNS Number 6092U. The content explicitly states it is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 and provides the total number of voting rights (1,550,268,075) as of June 30, 2024. This type of mandatory disclosure regarding the total voting rights, which serves as the denominator for shareholder notifications, falls under regulatory reporting concerning capital structure and voting rights. While it relates to capital, the specific nature of reporting the total voting rights count aligns best with a general regulatory announcement. Since there is no specific code for 'Voting Rights Notification' and it is a mandatory regulatory disclosure not fitting 10-K, ER, or IR, the most appropriate general regulatory category is RNS, as it is explicitly distributed by RNS and is a standard regulatory update.
2024-07-01 English
LYNPARZA & IMFINZI POSITIVE CHMP IN ENDOMETRIAL
Foreign Filer Report
2024-07-01 English
Lynparza & Imfinzi positive CHMP in endometrial
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details a positive opinion from the CHMP (Committee for Medicinal Products for Human Use) of the EMA regarding the approval of AstraZeneca's drugs (Lynparza and Imfinzi) in the EU for endometrial cancer. This type of announcement, which communicates a significant regulatory or corporate event (like a drug approval recommendation) via a formal news service, fits best under the general 'Regulatory Filings' category, as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder communication (DEF 14A, AGM-R). Since it is a general regulatory update disseminated through RNS, RNS is the most appropriate code.
2024-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.